LENZ Therapeutics, Inc.

Contributing Author

Recent Articles by LENZ Therapeutics, Inc.

Nov-05	LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights LENZ GlobeNewswire
Oct-29	LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025 LENZ GlobeNewswire
Sep-30	LENZ Therapeutics Announces Commercial Product Availability of VIZZ in the United States LENZ GlobeNewswire
Aug-25	LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences LENZ GlobeNewswire
Jul-31	LENZ Therapeutics Announces US FDA Approval of VIZZ for the Treatment of Presbyopia LENZ GlobeNewswire
Jul-30	LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights LENZ GlobeNewswire
Jul-28	LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia LENZ GlobeNewswire
Jul-07	LENZ Therapeutics and Laboratoires Thea Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada LENZ GlobeNewswire
May-27	LENZ Therapeutics to Present at Upcoming Investor Conferences LENZ GlobeNewswire
May-09	LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia LENZ GlobeNewswire
May-07	LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights LENZ GlobeNewswire
May-06	LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference LENZ GlobeNewswire